Literature DB >> 21761248

Optimal design in population kinetic experiments by set-valued methods.

Peter Gennemark1, Alexander Danis, Joakim Nyberg, Andrew C Hooker, Warwick Tucker.   

Abstract

We propose a new method for optimal experimental design of population pharmacometric experiments based on global search methods using interval analysis; all variables and parameters are represented as intervals rather than real numbers. The evaluation of a specific design is based on multiple simulations and parameter estimations. The method requires no prior point estimates for the parameters, since the parameters can incorporate any level of uncertainty. In this respect, it is similar to robust optimal design. Representing sampling times and covariates like doses by intervals gives a direct way of optimizing with rigorous sampling and dose intervals that can be useful in clinical practice. Furthermore, the method works on underdetermined problems for which traditional methods typically fail.

Mesh:

Year:  2011        PMID: 21761248      PMCID: PMC3231860          DOI: 10.1208/s12248-011-9291-8

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  11 in total

1.  The use of simulated annealing for finding optimal population designs.

Authors:  Stephen B Duffull; Sylvie Retout; France Mentré
Journal:  Comput Methods Programs Biomed       Date:  2002-07       Impact factor: 5.428

2.  POPED, a software for optimal experiment design in population kinetics.

Authors:  Marco Foracchia; Andrew Hooker; Paolo Vicini; Alfredo Ruggeri
Journal:  Comput Methods Programs Biomed       Date:  2004-04       Impact factor: 5.428

3.  A Bayesian A-optimal and model robust design criterion.

Authors:  Xiaojie Zhou; Lawrence Joseph; David B Wolfson; Patrick Bélisle
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

4.  Experimental design and efficient parameter estimation in population pharmacokinetics.

Authors:  M K al-Banna; A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

5.  The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Gordon Graham; Ivelina Gueorguieva; Leon Aarons
Journal:  Comput Methods Programs Biomed       Date:  2005-08-31       Impact factor: 5.428

6.  Estimating parameters for generalized mass action models using constraint propagation.

Authors:  Warwick Tucker; Zoltán Kutalik; Vincent Moulton
Journal:  Math Biosci       Date:  2006-12-08       Impact factor: 2.144

7.  Simultaneous optimal experimental design on dose and sample times.

Authors:  Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-03-25       Impact factor: 2.745

Review 8.  Application of optimal design methodologies in clinical pharmacology experiments.

Authors:  Kayode Ogungbenro; Aristides Dokoumetzidis; Leon Aarons
Journal:  Pharm Stat       Date:  2009 Jul-Sep       Impact factor: 1.894

9.  Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.

Authors:  M Tod; J M Rocchisani
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

10.  Optimal sampling times for pharmacokinetic experiments.

Authors:  D Z D'Argenio
Journal:  J Pharmacokinet Biopharm       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.